Results 151 to 160 of about 32,046 (240)

Monitoring the Electrical Phenotype of Transthyretin Amyloid Cardiomyopathy in the Era of Disease-Modifying Therapy. [PDF]

Circ Rep
Yonezu K, Kondo H, Takahashi N.
europepmc   +1 more source

Four Key Challenges After a Decade of Consecutive Paradigm Shifts in Wild-Type Transthyretin Amyloid Cardiomyopathy: From Rarely Found to Never Missed. [PDF]

Circ Rep
Kubota T.
europepmc   +1 more source

Differential Effects of Tafamidis on Cardiac Remodelling in Transthyretin Amyloid Cardiomyopathy: Evidence From Contemporary Imaging Data. [PDF]

Eur J Clin Invest
Quader T, Patel K, Sindone J, Khanna S, Bhat A, Chen H, Gan G, Nerlekar N, Eshoo S, Bart N, Thomas L, Sindone A.   +11 more
europepmc   +1 more source

Reply to: "A Network Meta-Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs". [PDF]

Eur J Neurol
da Silva Duarte GN, Machado TLGN, Rodrigues FAB, Conceição I, Pareyson D, da Costa JNMPG, task force of the EAN/PNS joint guideline for the management of neurological manifestations in hereditary transthyretin amyloidosis.   +6 more
europepmc   +1 more source

Incidental Diagnosis of TTR Amyloidosis During Left Bundle Branch Pacing Implantation: When Electrophysiology Meets Cardiomyopathy. [PDF]

JACC Case Rep
Costantino J, Proietti P, Ballatore F, Marchionni G, Zuccaro LM, Campoli M, Porcelli D, Romani B, Giordano C, Chimenti C.   +9 more
europepmc   +1 more source

Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses. [PDF]

BMC Cardiovasc Disord
Niazai A, Zurmati BM, Shah ST, Hikmat G, Sohaib HU, Zainab HH, Faridzai MJK, Nisar MR.   +7 more
europepmc   +1 more source

Early Amyloid Detection in Idiopathic Carpal Tunnel Syndrome: A Puzzling Gap Between Peripheral and Cardiac Involvement. [PDF]

J Clin Med
Martins A, Machado R, Pimenta S, Santos J, Osório H, Madureira P, Serdoura F, Fonseca E, Pereira B, Costa L, Martins E.   +10 more
europepmc   +1 more source

Time Lost Is Myocardium Lost: Why Earlier Recognition of ATTR Cardiomyopathy Matters. [PDF]

JACC Adv
Griffin JM, Geagea M.
europepmc   +1 more source

Evaluation of the Current ATTR-CM Treatment Landscape via a Mathematical Model of TTR Dissociation and Amyloid Formation. [PDF]

CPT Pharmacometrics Syst Pharmacol
Methven Jeknić S, Ahn-Horst TA, Ji AX, Ju JH, Paull M, Ji SG, Sinha U.   +6 more
europepmc   +1 more source

Complete Heart Block Unmasking Transthyretin Cardiac Amyloidosis: A Multimodality Imaging Case Report. [PDF]

Cureus
Erregui H, Moujahid M, Loudiyi N, Malki M, Lakhal Z, Benyass A.   +5 more
europepmc   +1 more source